30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ackermann Michael

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ackermann Michael's trades of Tarsus Pharmaceuticals, Inc.'s stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-09 2022-05-05
B Purchase
58,401 -45.9%
422.70
US$4,839,312 		58,401 -45.9% 422.70 US$4,839,312
2021-12-03 2021-12-01
PlS Planned sale
10,510 -20.1%
203.17
US$2,059,244 		10,510 -20.1% 203.17 US$2,059,244
2021-12-03 2021-12-01
PlS Planned sale
37,171 -17.5%
56.91
US$233,070 		37,171 -17.5% 56.91 US$233,070
2021-12-03 2021-12-01
PlS Planned sale
2,054 -0.2%
24.68
US$50,693 		2,054 -0.2% 24.68 US$50,693
2021-12-03 2021-12-01
PlS Planned sale
2,442 -0.2%
23.85
US$58,242 		2,442 -0.2% 23.85 US$58,242
2021-11-03 2021-11-01
PlS Planned sale
869 -0.1%
28.18
US$24,488 		869 -0.1% 28.18 US$24,488
2021-11-03 2021-11-01
PlS Planned sale
4,964 -0.4%
27.76
US$137,801 		4,964 -0.4% 27.76 US$137,801
2021-10-14 2021-10-12
PlS Planned sale
4,517 -0.4%
26.45
US$119,475 		4,517 -0.4% 26.45 US$119,475
2021-10-14 2021-10-12
PlS Planned sale
1,116 -0.1%
25.56
US$28,525 		1,116 -0.1% 25.56 US$28,525
2021-10-12 2021-10-08
PlS Planned sale
200 -0.0%
25.03
US$5,006 		200 -0.0% 25.03 US$5,006